CClinicalTrials.gg
RecruitingNCT06562504Updated Aug 20, 2024

Temporal Memory in Schizophrenic Patients

An interventional study of Transcranial direct current stimulation (tDCS)- anodal group and Transcranial direct current stimulation (tDCS)- sham group in Patients With Schizophrenia, sponsored by Xiaofeng Ma. Recruiting at 1 site in China. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-08-20.

Sponsored by Xiaofeng Ma · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Temporal order memory deficits are a central feature of cognitive abnormalities in schizophrenia. The dorsolateral prefrontal cortex contributes to the extraction of temporal contextual information. Transcranial direct current stimulation (tDCS) and interim testing have been shown to be external techniques that can improve temporal order memory deficits in schizophrenia patients. Transcranial alternating current stimulation (tACS) can also improve cognitive functioning in patients with schizophrenia. This study intends to investigate the learning effects of temporal order memory under two learning strategies during tDCS targeting the left dorsolateral prefrontal cortex (L-DLPFC) and transcranial direct current stimulation (tDCS) interventions in patients with schizophrenia, to investigate whether it can promote the retention of temporal order memory in patients, and to compare the differences in the effects of the two intervention modalities.

This study was planned to recruit 75 patients diagnosed with schizophrenia from the hospital.

A single online tDCS (2 mA × 20 min) and tACS (1.5 mA × 20 min, theta rhythm) intervention was conducted during which participants performed a temporal-sequence memory task for visual pictures, and test scores were compared for each stimulus type on an intermediate test and repetition of the two strategies of learning.

Read the detailed description

Treatment was conducted by two examiners, and participants' memory levels were tested before the start of the experiment using a flanker task and a numerical breadth task as baseline tests. The experimental procedure was divided into a learning phase, in which participants memorized the sequence of pictures, and a testing phase, in which participants were required to recall a picture presented after the probe item. Participants were randomly assigned in parallel to each stimulus type and learning strategy, with 25 receiving tdcs anodized stimuli, 25 receiving sham stimuli, and another 25 receiving tacs stimuli. And participants' inhibitory control continued to be tested using the flanker task before and after the stimuli for pre- and post-intervention comparisons.

02

Conditions studied

  • Patients With Schizophrenia

Browse trials for

03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's planned enrollment of 75 is close to the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

This is the only study on the registry with Xiaofeng Ma as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Meeting the diagnostic criteria for schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5);
  2. Aged 18 years or older, regardless of gender, with an educational level of elementary school or above;
  3. All patients received stable-level antipsychotic medication treatment, were in a stable phase of disease treatment, able to understand the testing requirements, and cooperated to complete all research tasks;
  4. No history of neurological disorders or other serious physical illnesses, and no history of intellectual disability;
  5. No color blindness, color weakness, or other color vision impairments, with normal vision or corrected vision.

Exclusion criteria

Exclusion Criteria:

  1. Clear cognitive impairment caused by somatic or cerebral organic lesions, such as cerebrovascular diseases, traumatic brain injury, etc;
  2. Individuals with mental disorders caused by substance dependence or abuse, or the use of psychoactive substances;
  3. History of brain injury or other central nervous system-related organic diseases;
  4. Individuals at significant risk of suicide or harming others;
  5. Participation in similar experiments in the past 30 days prior to baseline.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Anodal group

    In the anodal group, the anode was placed over the left DLPFC (F3), and the cathode was placed over the contralateral supraorbital area (FP2). A direct current of 2mA was applied for 20 minutes during each stimulation session.

    Device: Transcranial direct current stimulation (tDCS)- anodal group

  • Sham comparator
    Sham group

    In the sham group, the stimulation parameters, including the stimulation site and duration, were identical to those of the anodal group. However, during the 10-second ramp-up and ramp-down periods before and after stimulation, patients were unaware that the current was turned off.

    Device: Transcranial direct current stimulation (tDCS)- sham group

  • Experimental
    tACS group

    In the transcranial alternating current stimulation (tACS) group, the anode was placed in the left DLPFC (F3) and the cathode was placed in the contralateral supraorbital region (FP2). A direct current of 1.5 mA was applied for 20 minutes during each stimulation, theta rhythm, 6 HZ.

    Device: transcranial alternating current stimulation (tACS)-tACS group

Interventions

  • DeviceTranscranial direct current stimulation (tDCS)- anodal group

    2mA/20mins/session;

  • DeviceTranscranial direct current stimulation (tDCS)- sham group

    0mA/20mins/session

  • Devicetranscranial alternating current stimulation (tACS)-tACS group

    1.5 mA/20 min/session; 6HZ, theta

06

What researchers measure

Primary outcomes

  1. Correctness of temporal recall

    Stimulus content was presented using the Eprime experimental program, and participants pressed key responses during the test phase to record their rate of correctness. Stimulus content was presented using the Eprime experimental program, and participants pressed key responses during the test phase to record their rate of correctness.

    Time frame: 5mins to 24 hours

  2. proactive interference rate

    The rate of intrusion of prior information when participants recalled the current information was counted.

    Time frame: 5mins to 24 hours

07

Study locations

1 of 1 sites recruiting
  • Northwest Normal University
    Lanzhou, Gansu 730070, China
    • Xiaofeng Ma, Professor · Contact
    Recruiting
08

References and documents

Study documents

  • Study protocol · Jul 15, 2024
  • Informed consent form · Jul 15, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06562504
Lead sponsor
Xiaofeng Ma
Responsible party
Xiaofeng Ma (Professor, Northeast Normal University) — Sponsor-investigator
First posted
Aug 20, 2024
Start date
Aug 15, 2024
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Aug 20, 2024

Study contacts

Tiantian Li, Doctor
Contact
psylitiantian@outlook.com
13909483531
Xiaofeng Ma, Professor
principal investigator · Northwest Normal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion